And it also implies a better anti-tumor environment in the gastric cancer microenvironment because of a lower proportion of terminal-exhausted CD8+ T cells and a higher proportion of CD8+ Trm in the gastric cancer microenvironment (76). The gene discussed is CD8A; the disease is gastric cancer.